Chinook Therapeutics, Inc.
KDNYDelisted Aug 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001435049
Chinook Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 185 institutions reported holding it in 13F filings for Q2 2023, worth $2.24B in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Chinook Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
KDNY is no longer listed, so this page shows Q2 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 185
- +28 vs. Q1 2023
- Shares held
- 58.7M
- −2.83M (−4.6%) vs. Q1 2023
- Total value
- $2.24B
- +$821.6M (+57.8%) vs. Q1 2023
- New holders
- 65
- 59 more added
- Sold out
- 37
- 42 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KDNY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 2 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 2 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 2 | $0 |
| Q2 2023 | 185 | $2.24B |
| Q1 2023 | 157 | $1.42B |
| Q4 2022 | 155 | $1.52B |
| Q3 2022 | 151 | $1.12B |
| Q2 2022 | 135 | $930.3M |
| Q1 2022 | 105 | $727.3M |
| Q4 2021 | 103 | $707.4M |
| Q3 2021 | 85 | $361.6M |
| Q2 2021 | 89 | $372.0M |
| Q1 2021 | 77 | $366.1M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Chinook Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −116,562−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −92,200−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −56,703−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −54,054−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −48,875−100.0% | Sold out |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −31,060−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −30,927−100.0% | Sold out |
| Ziegler Capital Management, LLC | 0 | $0 | 0.00% | −26,725−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −25,220−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −25,169−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −17,166−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −16,329−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −13,856−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −13,437−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −13,060−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −4,474−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −4,052−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −1,490−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −144−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −107−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −68−100.0% | Sold out |